Sonnet biotherapeutics further expands global intellectual property portfolio with issuance of eu patent for fhab® platform technology

European patent office (epo) grants eu patent no. ep3583125 b1 covering the company's fully human albumin binding (fhab®) domain fusion proteins

SONN Ratings Summary

SONN Quant Ranking